Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Sinovac Biotech Ltd.

Newly Elected Directors of Sinovac Hold the First Board Meeting
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Announces New Board Member
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success’ New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders
From SINOVAC Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC’s Board of Directors Issues a Letter to Shareholders Outlining Clear Pathway to Restore Fairness and Deliver Value to All Shareholders
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2024 Annual Report
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Announces Record and Distribution Dates for Special Cash Dividend
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Announces Decision to Declare Cash Dividend
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Announces New Board Member and Chairman of the Audit Committee
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Issues Statement Regarding Privy Council Judgment
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Reports Unaudited First Half of 2024 Financial Results
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
Sinovac Amends Shareholder Rights Plan
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
Sinovac Announces Change of Legal Representative of Sinovac Beijing
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Reports Unaudited First Half of 2023 Financial Results
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
Sinovac Amends Shareholder Rights Plan
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Reports Unaudited First Half of 2022 Financial Results
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Varicella Vaccine Prequalified by WHO
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC to Showcase Products at CPHI Frankfurt
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
From Sinovac Biotech Ltd.
Via Business Wire
Tickers SVA
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.